Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-26T18:36:09.287Z Has data issue: false hasContentIssue false
  • English
  • Français

Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx

Published online by Cambridge University Press:  29 June 2007

Nina Zidar ,
Nina Gale ,
Andrej Cör  and
Vinko Kambič
Nina Zidar*
Affiliation:
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Nina Gale
Affiliation:
Institute of Pathology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Andrej Cör
Affiliation:
Institute of Histology and Embryology, Medical Faculty, University of LjubljanaLjubljana, Slovenia.
Vinko Kambič
Affiliation:
Slovenian Academy of Sciences and Art, Ljubljana, Slovenia.
*
Address for correspondence: Nina Zidar, M.D., Institute of Pathology, Medical Faculty, Korytkova 2, 1105 Ljubljana, Slovenia. Fax: +386 61 301 816.
Get access Rights & Permissions [Opens in a new window]

Abstract

In an attempt to analyse the proliferative activity in benign and malignant laryngeal epithelial lesions, and to determine the relationship to their histologic grade, we studied the expression of proliferative cell nuclear antigen (PCNA) and Ki-67 antigen on 20 squamous carcinomas, and on 30 biopsies of epithelial hyperplasia categorized according to the Kambiˇ-Lenart classification into simple, abnormal, and atypical hyperplasias. In simple hyperplasia, both antibodies stained the nuclei of the occasional cells in the basal layer. In abnormal hyperplasia (mild dysplasia), positive cells occupied up to a third, and in atypical hyperplasia (moderate and severe dysplasia) they occupied from two-thirds to the entire epithelial thickness. In squamous carcinoma, we have found a statistically significant correlation between its grade and the percentage of Ki-67-(p<0.01) and PCNA-(p<0.00001) positive cells. Our results suggest that the proliferative fraction progressively increases with the degree of epithelial hyperplasia and the grade of carcinoma. We conclude that the patterns of immunoreactivity to PCNA and Ki-67 antigen correspond to the histologic grade of both benign and malignant epithelial lesions of the larynx. This method should be regarded as a useful adjunct to traditional histological techniques allowing more objective grading of benign and malignant epithelial lesions.

Keywords

Laryngeal neoplasmsCarcinoma, squamous cellEpithelial cells, hyperplasiaImmunohistochemistry
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 110 , Issue 5 , May 1996 , pp. 440 - 445
Copyright
Copyright © JLO (1984) Limited 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

A part of the study was presented at the XVth European Congress of Pathology in Copenhagen, September 3–9, 1995.

References

Brown, D. C.Gatter, K. C. (1990) Monoclonal antibody Ki-67; its use in histopathology. Histopathology 17: 489–503.CrossRefGoogle ScholarPubMed
Coltrera, M. D., Zarbo, R. J., Sakr, W. A., Gown, A. M. (1992) Markers of dysplasia of the upper aerodigestive tract. American Journal of Pathology 141: 817–825.Google ScholarPubMed
Crissman, J. D. (1993) Upper aerodigestive tract. In Pathology of Incipient Neoplasia. 2nd Edition. (Henson, D. E., Albores-Saavedra, J., eds.), Saunders, Philadelphia, pp 44–63.Google Scholar
Ferlito, A., Friedmann, I. (1993) Squamous cell carcinoma. In Neoplasms of the Larynx. 1st Edition. (Ferlito, A., ed.), Churchill Livingstone, Edinburgh, pp 113–133.Google Scholar
Haerslev, T., Jacobsen, G. K. (1995) An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis. Human Pathology 26: 295–301.CrossRefGoogle ScholarPubMed
Hall, P. A., Levison, D. A., Woods, A. L., Yu, C. C. W., Kellock, D. B., Watkins, J. A., Barnes, D. M., Gillett, C. E., Camplejohn, R., Dover, R., Waseem, N. H., Lane, D. P. (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. Journal of Pathology 162: 285–294.CrossRefGoogle ScholarPubMed
Kambič, V., Lenart, I. (1971) Notre classification des hyperplasies de l'épithelium du larynx au point de vue pronostic. Journal Français d'Oto-Rhino-Laryngologie 20: 1145–1150.Google Scholar
Kambič, V. (1978) Difficulties in management of vocal cord precancerous lesions. Journal of Laryngology and Otology 92: 305–315.CrossRefGoogle Scholar
Kambič, V., Gale, N. (1986) Significance of keratosis and dyskeratosis for classifying hyperplastic aberrations of laryngeal mucosa. American Journal of Otolaryngology 7: 323–333.CrossRefGoogle ScholarPubMed
Kambič, V., Gale, N., Ferluga, D. (1992) Laryngeal hyperplastic lesions, follow-up study and application of lectins and anticytokeratins for their evaluation. Pathology, Research and Practice 188: 1067–1077.CrossRefGoogle ScholarPubMed
Kambič, V., Gale, N. (1995) Epithelial Hyperplastic Lesions of the Larynx, 1st Edition, Elsevier, Amsterdam, pp 39–162.Google Scholar
Kearsley, J. H., Furlong, K. L., Cooke, R. A., Waters, M. J. (1990) An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. British Journal of Cancer 61: 821–827.CrossRefGoogle ScholarPubMed
Linden, M. D., Chan, K., Kubus, J., Brown, R. D., Zarbo, R. J. (1993) Ki-67 and proliferating cell nuclear antigen tumour proliferative indices in DNA diploid colorectal adenocarcinomas. American Journal of Clinical Pathology 100: 206–212.CrossRefGoogle ScholarPubMed
Mittal, K. R., Demopoulos, R. I., Goswami, S. (1993) Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia. American Journal of Surgical Pathology 17: 117–122.CrossRefGoogle ScholarPubMed
Munck-Wikland, E., Edström, S., Jungmark, E., Kuylenstierna, R., Lindholm, J., Auer, G. (1994) Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. International Journal of Cancer 56: 95–99.CrossRefGoogle ScholarPubMed
Nishioka, H., Hiasa, Y., Hayashi, I., Kitahori, Y., Konishi, N., Sugimura, M. (1993) Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 50: 426–429.CrossRefGoogle ScholarPubMed
Sabattini, E., Gerdes, J., Gherlinzoni, F., Poggi, S., Zucchini, L., Melilli, G., Grigioni, F., del Vecchio, M. T., Leoncini, L., Falini, B., Pileri, S. A. (1993) Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. Journal of Pathology 169: 397–403.CrossRefGoogle ScholarPubMed
Scott, R. J., Hall, P. A., Haldane, J. S., Van Noorden, S., Price, Y., Lane, D. P., Wright, N. (1991) A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. Journal of Pathology 165: 173–178.CrossRefGoogle ScholarPubMed
Shanmugaratnam, K., Sobin, L. H. (1991) Histological Typing of Tumours of the Upper Respiratory Tract and Ear, 2nd Edition, Springer-Verlag, Berlin, pp 26–28.CrossRefGoogle Scholar
Shin, D. M., Voravud, N., Ro, J. Y., Lee, J. S., Hong, W. K., Hittelman, W. N. (1993) Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker. Journal of the National Cancer Institute 85: 971–978.CrossRefGoogle ScholarPubMed
Shurbaji, M. S., Brooks, S. K., Thurmond, T. S. (1993) Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium. American Journal of Clinical Pathology 100: 22–26.CrossRefGoogle ScholarPubMed
Thomas, M., Noguchi, M., Kitagawa, H., Kinoshita, K., Miyazaki, I. (1993) Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma. Journal of Clinical Pathology 46: 525–528.CrossRefGoogle ScholarPubMed